Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FFBN8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,944
Award facts
- Contract value 100% obligated
- $15,944.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $15,944.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 52 mg Mirena systems (a contraceptive intrauterine device). The delivery order, issued on December 3, 2025, with an ultimate completion date of December 24, 2025, contains no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract vehicle established on November 13, 2025, to support recurring medical supply needs of military healthcare facilities worldwide through December 31, 2036.
DMS Pharmaceutical Group serves as a critical regional pharmaceutical supplier within the broader $30.3 billion PPV-G GEN V acquisition strategy, which authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The company's extensive product portfolio and established performance across numerous delivery orders demonstrate its capability to fulfill the diverse and specialized pharmaceutical requirements of Department of Defense healthcare operations globally, with the Mirena delivery order representing one component of the vendor's substantial federal contracting activity supporting military medical supply chains.
Quick answers
Who was awarded contract SPE2DR26FFBN8?
SPE2DR26FFBN8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FFBN8 worth?
The government has obligated $15,944 on SPE2DR26FFBN8.
Is contract SPE2DR26FFBN8 an order under another contract?
Yes. SPE2DR26FFBN8 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBN8 competed?
The extent of competition for SPE2DR26FFBN8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award